We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+10.79%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$154M
AUM Growth
-$30M
Cap. Flow
-$33.2M
Cap. Flow %
-21.62%
Top 10 Hldgs %
41.01%
Holding
85
New
17
Increased
10
Reduced
29
Closed
24

Top Buys

Rank Stock Value
1
HUM icon
Humana
HUM
+$5.56M
2
SUPN icon
Supernus Pharmaceuticals
SUPN
+$1.98M
3
AKCA
Akcea Therapeutics Inc
AKCA
+$1.96M
4
PBYI icon
Puma Biotechnology
PBYI
+$1.96M
5
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$1.93M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$5.61M
2
AET
Aetna Inc
AET
+$4.53M
3
LLY icon
Eli Lilly
LLY
+$3.42M
4
GKOS icon
Glaukos
GKOS
+$3.3M
5
XLRN
Acceleron Pharma
XLRN
+$2.61M

Sector Composition

Rank Sector Weight
1 Healthcare 81.64%
2 Energy 0.6%
3 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESPR
1
DELISTED
Esperion Therapeutics
ESPR
$10.9M 7.08%
165,000
+15,000
+10% +$808K
CELG
2
DELISTED
Celgene Corp
CELG
$7.83M 5.1%
75,000
– –
IMMU
3
DELISTED
Immunomedics Inc
IMMU
$7.27M 4.74%
450,000
-50,000
-10% -$590K
BIIB icon
4
Biogen
BIIB
$30B
$7.01M 4.56%
22,000
+2,000
+10% +$642K
HUM icon
5
Humana
HUM
$43.7B
$5.58M 3.64%
+22,500
New +$5.56M
AERI
6
DELISTED
Aerie Pharmaceuticals
AERI
$5.08M 3.31%
85,000
-15,000
-15% -$910K
CI icon
7
Cigna
CI
$73.7B
$5.08M 3.31%
25,000
-1,500
-6% -$299K
GBT
8
DELISTED
Global Blood Therapeutics, Inc.
GBT
$4.92M 3.2%
125,000
– –
ABBV icon
9
AbbVie
ABBV
$443B
$4.84M 3.15%
50,000
-15,000
-23% -$1.41M
MRK icon
10
Merck
MRK
$322B
$4.5M 2.93%
83,840
+5,240
+7% +$290K
ABT icon
11
Abbott
ABT
$183B
$4.28M 2.79%
75,000
-10,000
-12% -$554K
CLVS
12
DELISTED
Clovis Oncology, Inc.
CLVS
$4.08M 2.66%
60,000
-20,000
-25% -$1.4M
ANAB icon
13
AnaptysBio
ANAB
$1.58B
$4.03M 2.62%
40,000
-10,000
-20% -$736K
KTWO
14
DELISTED
K2M Group Holdings, Inc
KTWO
$3.15M 2.05%
175,000
-25,000
-13% -$475K
BMY icon
15
Bristol-Myers Squibb
BMY
$133B
$3.06M 2%
50,000
-5,000
-9% -$313K
SRRA
16
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$2.98M 1.94%
20,000
+5,000
+33% +$481K
TSRO
17
DELISTED
TESARO, Inc.
TSRO
$2.9M 1.89%
35,000
+10,000
+40% +$980K
KPTI icon
18
Karyopharm Therapeutics
KPTI
$43.5M
$2.88M 1.88%
20,000
-6,667
-25% -$1.07M
DERM
19
DELISTED
Dermira, Inc.
DERM
$2.78M 1.81%
100,000
-25,000
-20% -$663K
JUNO
20
DELISTED
Juno Therapeutics, Inc.
JUNO
$2.74M 1.79%
60,000
-15,000
-20% -$748K
ZBH icon
21
Zimmer Biomet
ZBH
$18.2B
$2.71M 1.77%
23,175
-7,725
-25% -$874K
SGMO
22
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$2.46M 1.6%
150,000
-50,000
-25% -$744K
XENT
23
DELISTED
Intersect ENT, Inc
XENT
$2.43M 1.58%
75,000
-15,000
-17% -$450K
DHR icon
24
Danaher
DHR
$137B
$2.32M 1.51%
28,200
-11,280
-29% -$917K
RARE icon
25
Ultragenyx Pharmaceutical
RARE
$2.45B
$2.32M 1.51%
50,000
– –
1
2 3 4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q4 2017 Portfolio in Review

As of Q4 2017, Iguana Healthcare Management held 85 positions worth $154M, down 16% from $184M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Iguana Healthcare Management withdrew a net $33.2M in Q4 2017, closing 24 positions and reducing 29 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $5.61M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 82% of assets, up from 77% a quarter earlier, followed by Energy and Financials.

Against the trend, Iguana Healthcare Management opened a new position in Humana worth $5.58M.

  • Iguana Healthcare Management's largest Q4 2017 buy was Humana: 22,500 shares worth $5.58M.
  • Iguana Healthcare Management added most to Ionis Pharmaceuticals in Q4 2017, an estimated $1.37M increase.
  • Iguana Healthcare Management's biggest Q4 2017 reduction was Boston Scientific, cutting an estimated $2.07M.
  • Iguana Healthcare Management fully exited Alexion Pharmaceuticals in Q4 2017, selling an estimated $5.61M.
  • Iguana Healthcare Management's ten largest holdings make up 41% of its $154M portfolio in Q4 2017.
  • Iguana Healthcare Management opened 17 new positions and closed 24 in Q4 2017.
  • Iguana Healthcare Management's portfolio value fell 16% quarter-over-quarter to $154M.

Based on Iguana Healthcare Management's 13F filing for Q4 2017, filed 14 Feb 2018.